Astrazeneca Launches A Smarter Approach To Asthma Management In Europe
AstraZeneca today announced that 37 countries to date have received approval of SymbicortŪ Maintenance And Reliever Therapy (Symbicort SMARTŪ), and that a period of world wide launches will now be initiated. This new, smarter approach to asthma is the first to provide patients with both asthma maintenance and reliever therapy together in just one inhaler. [click link for full article]